KYNB Stock — Kyntra Bio, Inc.: Metrics

Market overview

2 metrics

Share price

$8.49

Market cap

$34.01M

Price action

19 metrics

Price change (1W)

+5.2%

Price change (30D)

+23.3%

Price change (3M)

+25.3%

Price change (6M)

+23.3%

Price change (YTD)

-2.8%

Price change (1Y)

-30.0%

Trailing year

Price change (5Y)

—

52-week high

$12.43

52-week low

$6.46

Change from 52-week high

-31.4%

Change from 52-week low

+32.0%

Annualized volatility

54.3%

Beta

1.1

RSI (14D)

72.0

Price vs SMA 50

+16.8%

Price vs SMA 200

+12.4%

Avg volume (3M)

20,912

Relative volume

2.0

Average dollar volume

$152,154

Company

3 metrics

Sector

Healthcare

Industry

Biotechnology

Shares outstanding

4.05M

Valuation

12 metrics

P / E (TTM)

0.2

Trailing earnings · reciprocal yield 531.1%

PEG ratio

—

EV / revenue

—

EV / EBITDA

—

EV / EBIT

—

P / sales

7.0×

reciprocal yield 14.3%

P / book

—

FCF yield

-118.2%

TTM · current market cap

Buyback yield

—

P / FCF

—

P / operating cash flow

—

Earnings yield

569.1%

Historical valuation

8 metrics

P / E historical average (3Y)

—

P / E historical average (5Y)

—

EV / revenue historical average (3Y)

—

EV / revenue historical average (5Y)

—

EV / EBIT historical average (3Y)

—

EV / EBIT historical average (5Y)

—

EV / EBITDA historical average (3Y)

—

EV / EBITDA historical average (5Y)

—

Dividends & buybacks

7 metrics

Dividend yield

—

Trailing 12 months

Payout ratio

—

Shareholder yield

—

Dividend / share (TTM)

—

Dividend growth YoY

—

Dividend growth streak

—

Last ex-dividend

—

Earnings calendar

2 metrics

Next earnings

—

Last earnings

2026-08-13

Profitability

9 metrics

Gross margin

6.3%

Operating margin

-1,089.8%

Trailing 12 months

Net margin

3,967.8%

Gross profit (TTM)

—

Operating profit (TTM)

−$50.31M

Net income (TTM)

$183.19M

Trailing 12 months

Diluted EPS (TTM)

$45.30

FCF margin

-824.4%

Effective tax rate

—

Per share

11 metrics

Revenue per diluted share (TTM)

—

Gross profit per diluted share (TTM)

—

Operating profit per diluted share (TTM)

—

EBITDA per diluted share (TTM)

—

Net income per diluted share (TTM)

—

Operating cash flow per diluted share (TTM)

—

Free cash flow per diluted share (TTM)

—

Capital expenditures per diluted share (TTM)

—

R&D per diluted share (TTM)

—

Stock compensation per diluted share (TTM)

—

Book value per share

$93.74

Growth

11 metrics

Revenue growth YoY

-209.3%

Year over year

Net income growth YoY

—

Revenue (TTM)

$4.62M

Trailing 12 months

EPS growth YoY

—

Shares change YoY

+0.1%

Year over year · more shares

Revenue CAGR (3Y)

-64.2%

Revenue CAGR (5Y)

-48.4%

EPS CAGR (3Y)

—

EPS CAGR (5Y)

—

FCF CAGR (3Y)

—

FCF CAGR (5Y)

—

Quality

14 metrics

Return on equity

—

Return on assets

181.2%

Debt / equity

—

Current ratio

2.7

EBITDA (TTM)

—

Free cash flow (TTM)

−$38.06M

Quick ratio

2.6

Interest coverage

-5.4

Net debt / EBITDA

—

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Cash & equivalents

$50.64M

Total assets

$101.08M

Total debt

$75.00M

Cash flow & spend

7 metrics

Operating cash flow (TTM)

−$38.05M

Capital expenditures (TTM)

$9,000

R&D (TTM)

$22.86M

SG&A (TTM)

$27.67M

Stock compensation (TTM)

$3.99M

R&D / revenue

495.2%

Stock compensation / revenue

86.3%

Ownership (13F)

3 metrics

13F filers

28

13F filer change QoQ

-5

Institutional ownership

26.9%

Short interest

3 metrics

Short interest

2.4%

Latest settlement · 14.2 days to cover

Days to cover

14.2d

Short-squeeze score

67 / 100

Insider activity

2 metrics

Net insider buying (90D)

—

Insider-sentiment score

—

Risk flags

1 metrics

Going concern

—

KYNB · Kyntra Bio, Inc.

KYNB metrics

Market overview

Price action

Company

Valuation

Historical valuation

Dividends & buybacks

Earnings calendar

Profitability

Growth

Quality

Cash flow & spend

Ownership (13F)

Short interest

Insider activity

Risk flags

No metrics match that search